The authors investigated the association between nonalcoholic fatty liver disease (NAFLD) and gastrointestinal tract cancer in the general population.
Alcohol-related liver disease is associated with significant changes in gut microbial composition.
Prof Jean-François Dufour, Switzerland, addresses the important problem of comorbidities in NASH management including diabetes, cardiovascular disease, cancer. This video was filmed in Boston during the Liver meeting 2019.
Prof Pierre-Emmanuel Rautou, France sheds light on the role of liver sinusoidal endothelial cells in NASH development. This video was flmed in Boston during the Liver meeting 2019.
Given the ongoing developments with COVID-19, ILC 2020 is postponed to 25-28 August 2020 in London at the same venue.
At the International Liver Congress 2020, EASL is turning its attention to health in daily life and its importance in protecting the liver. Doctors, patients and patient groups, allied health professionals and policymakers will discuss the important new insights and information to help combat liver disease.
Prof Gracia-Sancho, Spain, discusses his oral presentation at the Liver meeting 2019 in Boston and the reasons why PPAR agonists could be a very valuable therapeutic option for the treatment of advanced chronic liver disease.